Armstrong Advisory Group, Inc Bristol Myers Squibb CO Transaction History
Armstrong Advisory Group, Inc
- $1.22 Billion
- Q2 2025
A detailed history of Armstrong Advisory Group, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 5,181 shares of BMY stock, worth $241,175. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,181
Previous 6,148
15.73%
Holding current value
$241,175
Previous $374,000
36.1%
% of portfolio
0.02%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,665Shares Held
1.6BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...